Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Suppression of enteric pathogens via bacteriocins is a protective mechanism in the gut where commensal microbes produce small, ribosomally synthesized peptides called bacteriocins to inhibit or kill pathogenic bacteria. This natural antagonism helps maintain gut health, prevents infections, and shapes the microbial ecosystem. The process is mediated by various species (notably Lactobacillus, Streptococcus, Clostridium, and Bacillus) that produce different classes and families of bacteriocins, which act through mechanisms such as pore formation, membrane disruption, resource competition, and modulation of the host immune response. This process underlies the concept of "colonization resistance" and is a major reason why probiotics and certain bacteriocins are studied as preventive or adjunctive therapies for gastrointestinal infections and dysbiosis.
The mechanism involves direct killing or inhibition of pathogens via pore formation or membrane disruption by bacteriocins, niche exclusion by occupying space and resources to prevent pathogen colonization, and immune modulation through enhancement of host defenses against pathogens.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppression of enteric pathogens via bacteriocins.